HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

The effect of blood glutamate scavengers oxaloacetate and pyruvate on neurological outcome in a rat model of subarachnoid hemorrhage.

Abstract
Blood glutamate scavengers have been shown to effectively reduce blood glutamate concentrations and improve neurological outcome after traumatic brain injury and stroke in rats. This study investigates the efficacy of blood glutamate scavengers oxaloacetate and pyruvate in the treatment of subarachnoid hemorrhage (SAH) in rats. Isotonic saline, 250 mg/kg oxaloacetate, or 125 mg/kg pyruvate was injected intravenously in 60 rats, 60 minutes after induction of SAH at a rate of 0.1 ml/100 g/min for 30 minutes. There were 20 additional rats that were used as a sham-operated group. Blood samples were collected at baseline and 90 minutes after SAH. Neurological performance was assessed at 24 h after SAH. In half of the rats, glutamate concentrations in the cerebrospinal fluid were measured 24 h after SAH. For the remaining half, the blood brain barrier permeability in the frontal and parieto-occipital lobes was measured 48 h after SAH. Blood glutamate levels were reduced in rats treated with oxaloacetate or pyruvate at 90 minutes after SAH (p < 0.001). Cerebrospinal fluid glutamate was reduced in rats treated with pyruvate (p < 0.05). Neurological performance was significantly improved in rats treated with oxaloacetate (p < 0.05) or pyruvate (p < 0.01). The breakdown of the blood brain barrier was reduced in the frontal lobe in rats treated with pyruvate (p < 0.05) and in the parieto-occipital lobes in rats treated with either pyruvate (p < 0.01) or oxaloacetate (p < 0.01). This study demonstrates the effectiveness of blood glutamate scavengers oxaloacetate and pyruvate as a therapeutic neuroprotective strategy in a rat model of SAH.
AuthorsMatthew Boyko, Israel Melamed, Benjamin Fredrick Gruenbaum, Shaun Evan Gruenbaum, Sharon Ohayon, Akiva Leibowitz, Evgeny Brotfain, Yoram Shapira, Alexander Zlotnik
JournalNeurotherapeutics : the journal of the American Society for Experimental NeuroTherapeutics (Neurotherapeutics) Vol. 9 Issue 3 Pg. 649-57 (Jul 2012) ISSN: 1878-7479 [Electronic] United States
PMID22711471 (Publication Type: Journal Article, Research Support, Non-U.S. Gov't)
Chemical References
  • Antioxidants
  • Oxaloacetic Acid
  • Glutamic Acid
  • Pyruvic Acid
Topics
  • Animals
  • Antioxidants (metabolism, therapeutic use)
  • Blood-Brain Barrier (drug effects, physiopathology)
  • Disease Models, Animal
  • Glutamic Acid (blood, cerebrospinal fluid)
  • Male
  • Nervous System Diseases (blood, cerebrospinal fluid, drug therapy, etiology)
  • Oxaloacetic Acid (blood, therapeutic use)
  • Pyruvic Acid (blood, therapeutic use)
  • Rats
  • Rats, Sprague-Dawley
  • Statistics, Nonparametric
  • Subarachnoid Hemorrhage (blood, cerebrospinal fluid, complications, drug therapy)
  • Time Factors

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: